Association between cardiotrophin 1 levels and central blood pressure in untreated patients with essential hypertension. 2014

Eugenia Gkaliagkousi, and Eleni Gavriilaki, and Barbara Nikolaidou, and Fani Chatzopoulou, and Panagiota Anyfanti, and Areti Triantafyllou, and Konstantinos Petidis, and Chrysanthos Zamboulis, and Stella Douma
2nd Propedeutic Department of Internal Medicine, Aristotle University of Thessaloniki, Thessaloniki, Greece.

BACKGROUND Cardiotrophin 1 (CT-1) is an interleukin 6-related cytokine recently implicated in cardiac hypertrophy and vascular damage in essential hypertension (EH). We aimed first to determine CT-1 levels in naive, untreated patients with grade I EH (UH) as compared with normotensive (NT) individuals and, second, to investigate a possible association of CT-1 levels with indices of arterial stiffness. METHODS We enrolled 45 consecutive untreated patients recently diagnosed with grade I EH by means of office and ambulatory blood pressure (BP) measurements and 25 age- and sex-matched NT subjects. CT-1 levels were measured with a commercially available enzyme-linked immunosorbent assay kit, and indices of arterial stiffness were determined by applanation tonometry. RESULTS CT-1 levels were significantly elevated in UH patients compared with NT subjects (P < 0.001). Furthermore, CT-1 levels correlated positively with office, ambulatory and central BP. A significant bivariable correlation was also found between CT-1 levels and pulse wave velocity (P = 0.02). In the multivariable analysis, central systolic and diastolic BP proved the only significant predictors of CT-1 levels after controlling for other related factors. CONCLUSIONS To our knowledge, this is the first study that correlates CT-1 levels with ambulatory and central BP, as well as with pulse wave velocity in patients with essential hypertension. Thus, studying the effects of CT-1 in the cardiovascular system in patients with EH represents a promising area of investigation in the future.

UI MeSH Term Description Entries
D006973 Hypertension Persistently high systemic arterial BLOOD PRESSURE. Based on multiple readings (BLOOD PRESSURE DETERMINATION), hypertension is currently defined as when SYSTOLIC PRESSURE is consistently greater than 140 mm Hg or when DIASTOLIC PRESSURE is consistently 90 mm Hg or more. Blood Pressure, High,Blood Pressures, High,High Blood Pressure,High Blood Pressures
D008297 Male Males
D008365 Manometry Measurement of the pressure or tension of liquids or gases with a manometer. Tonometry,Manometries
D008875 Middle Aged An adult aged 45 - 64 years. Middle Age
D011237 Predictive Value of Tests In screening and diagnostic tests, the probability that a person with a positive test is a true positive (i.e., has the disease), is referred to as the predictive value of a positive test; whereas, the predictive value of a negative test is the probability that the person with a negative test does not have the disease. Predictive value is related to the sensitivity and specificity of the test. Negative Predictive Value,Positive Predictive Value,Predictive Value Of Test,Predictive Values Of Tests,Negative Predictive Values,Positive Predictive Values,Predictive Value, Negative,Predictive Value, Positive
D011379 Prognosis A prediction of the probable outcome of a disease based on a individual's condition and the usual course of the disease as seen in similar situations. Prognostic Factor,Prognostic Factors,Factor, Prognostic,Factors, Prognostic,Prognoses
D001794 Blood Pressure PRESSURE of the BLOOD on the ARTERIES and other BLOOD VESSELS. Systolic Pressure,Diastolic Pressure,Pulse Pressure,Pressure, Blood,Pressure, Diastolic,Pressure, Pulse,Pressure, Systolic,Pressures, Systolic
D004797 Enzyme-Linked Immunosorbent Assay An immunoassay utilizing an antibody labeled with an enzyme marker such as horseradish peroxidase. While either the enzyme or the antibody is bound to an immunosorbent substrate, they both retain their biologic activity; the change in enzyme activity as a result of the enzyme-antibody-antigen reaction is proportional to the concentration of the antigen and can be measured spectrophotometrically or with the naked eye. Many variations of the method have been developed. ELISA,Assay, Enzyme-Linked Immunosorbent,Assays, Enzyme-Linked Immunosorbent,Enzyme Linked Immunosorbent Assay,Enzyme-Linked Immunosorbent Assays,Immunosorbent Assay, Enzyme-Linked,Immunosorbent Assays, Enzyme-Linked
D005260 Female Females
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man

Related Publications

Eugenia Gkaliagkousi, and Eleni Gavriilaki, and Barbara Nikolaidou, and Fani Chatzopoulou, and Panagiota Anyfanti, and Areti Triantafyllou, and Konstantinos Petidis, and Chrysanthos Zamboulis, and Stella Douma
April 2015, Zhonghua xin xue guan bing za zhi,
Eugenia Gkaliagkousi, and Eleni Gavriilaki, and Barbara Nikolaidou, and Fani Chatzopoulou, and Panagiota Anyfanti, and Areti Triantafyllou, and Konstantinos Petidis, and Chrysanthos Zamboulis, and Stella Douma
February 2018, Clinica chimica acta; international journal of clinical chemistry,
Eugenia Gkaliagkousi, and Eleni Gavriilaki, and Barbara Nikolaidou, and Fani Chatzopoulou, and Panagiota Anyfanti, and Areti Triantafyllou, and Konstantinos Petidis, and Chrysanthos Zamboulis, and Stella Douma
September 2001, Clinical and experimental medicine,
Eugenia Gkaliagkousi, and Eleni Gavriilaki, and Barbara Nikolaidou, and Fani Chatzopoulou, and Panagiota Anyfanti, and Areti Triantafyllou, and Konstantinos Petidis, and Chrysanthos Zamboulis, and Stella Douma
May 2024, The American journal of the medical sciences,
Eugenia Gkaliagkousi, and Eleni Gavriilaki, and Barbara Nikolaidou, and Fani Chatzopoulou, and Panagiota Anyfanti, and Areti Triantafyllou, and Konstantinos Petidis, and Chrysanthos Zamboulis, and Stella Douma
November 2022, Healthcare (Basel, Switzerland),
Eugenia Gkaliagkousi, and Eleni Gavriilaki, and Barbara Nikolaidou, and Fani Chatzopoulou, and Panagiota Anyfanti, and Areti Triantafyllou, and Konstantinos Petidis, and Chrysanthos Zamboulis, and Stella Douma
November 2007, Hypertension (Dallas, Tex. : 1979),
Eugenia Gkaliagkousi, and Eleni Gavriilaki, and Barbara Nikolaidou, and Fani Chatzopoulou, and Panagiota Anyfanti, and Areti Triantafyllou, and Konstantinos Petidis, and Chrysanthos Zamboulis, and Stella Douma
July 2002, American journal of hypertension,
Eugenia Gkaliagkousi, and Eleni Gavriilaki, and Barbara Nikolaidou, and Fani Chatzopoulou, and Panagiota Anyfanti, and Areti Triantafyllou, and Konstantinos Petidis, and Chrysanthos Zamboulis, and Stella Douma
March 2008, Journal of hypertension,
Eugenia Gkaliagkousi, and Eleni Gavriilaki, and Barbara Nikolaidou, and Fani Chatzopoulou, and Panagiota Anyfanti, and Areti Triantafyllou, and Konstantinos Petidis, and Chrysanthos Zamboulis, and Stella Douma
February 2009, American journal of hypertension,
Eugenia Gkaliagkousi, and Eleni Gavriilaki, and Barbara Nikolaidou, and Fani Chatzopoulou, and Panagiota Anyfanti, and Areti Triantafyllou, and Konstantinos Petidis, and Chrysanthos Zamboulis, and Stella Douma
January 2013, Clinical and experimental hypertension (New York, N.Y. : 1993),
Copied contents to your clipboard!